Franklin Genomic Advancements ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.50
資產淨值: 42.49
成立日期: 25/02/2020
 
分析
市值分佈:
92.25%
大市值
4.95%
中市值
0.17%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:06) 總持有投資項目: 63  
0%
 
100%
     10大 (48.94%)
代號 名稱 佔比% ▼ 持有日期
ARGNFArgen X NV1.4031/10/2026
JAZZJazz Pharmaceuticals plc1.2031/10/2026
RPRXRoyalty Pharma plc1.0431/10/2026
IQVIQVIA Holdings1.0430/09/2026
TXG10x Genomics1.0431/10/2026
BNTXBioNTech SE American Depositary Share1.0231/10/2026
HNGEHinge Health Inc.1.0231/10/2026
VCYTVeracyte1.0130/09/2026
PRAXPraxis Precision Medicines0.9731/10/2026
PTCTPTC Therapeutics0.9531/10/2026
STOKStoke Therapeutics0.9530/09/2026
SUVPFSartorius AG0.9331/10/2026
INSMInsmed Incorporated0.9031/10/2026
KNSAKiniksa Pharmaceuticals International, plc0.9030/09/2026
CRSPCRISPR Therapeutics AG0.8930/09/2026
RVMDRevolution Medicines0.8731/10/2026
GMABGenmab A/S ADS0.8631/10/2026
MRNAModerna0.6831/10/2026
AAgilent Technologies0.6731/10/2026
TRAXFirst Tracks Biotherapeutics Inc.0.6731/10/2026
  1   2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.